| Name: | Glimepiride EP Impurity B |
| Catalogue No. | VL71002 |
| CAS No. | 119018-29-0 |
| Molecular Formula | C16H21N3O4S |
| Molecular Weight | 351.42 |
| Status | In-stock |
| IUPAC Name | 4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide |
| Synonyms | Glimepiride Related Compound B / Glimepiride BP Impurity B / Glimepiride Sulfonamide |
| Appearance | White Powder |
| Description | Glimepiride Related Compound B (Glimepiride sulfonamide) is a drug intermediate used for the synthesis of glimepiride. Glimepiride sulfonamide has antidiabetic potential mainly by DPP-IV inhibition, but also through insulin stimulation and alpha-amylase inhibition. |
| References | Pathare, Dnyandeo B., et al. “RP-LC Determination of the Cis-Isomer of Glimepiride in a Bulk Drug Substance.” Chromatographia, vol. 66, no. 7-8, Sept. 2007, pp. 639–41, https://doi.org/10.1365/s10337-007-0356-x. |
